Doctors Note Logo

Published on: 9/23/2026

Do adults get RSV, and who is at highest risk?

Yes, adults do get RSV, and infection can range from mild cold-like symptoms to serious lower respiratory illness such as bronchiolitis or pneumonia. Risk of severe disease is highest in adults age 60 and older, those with chronic heart or lung conditions like COPD, asthma, or heart failure, people with weakened immune systems, adults with diabetes or obesity, and residents of nursing homes or long-term care facilities. Reinfection is common throughout life because immunity after RSV is short-lived, so a previous case does not protect you. There are several important details to consider, including warning signs that call for urgent care and who may benefit from RSV vaccination, so review the complete answer below.

If you are coughing, wheezing, or feeling short of breath and unsure whether it is RSV, flu, COVID-19, or something else, guessing can delay treatment that works best in the first few days of illness. A free, instant, online symptom check lets you describe what you are experiencing in a few minutes and receive possible causes along with clear guidance on whether to rest at home, book a visit, or seek urgent care, so you can act with confidence instead of uncertainty.

Last reviewed for medical accuracy: 09/23/2026

answer background

Explanation

Do adults get RSV, and who is at highest risk?

Respiratory syncytial virus (RSV) is often thought of as a childhood illness, but adults can—and do—get RSV. Understanding who’s most at risk, how it presents, and what you can do to protect yourself helps keep you and those around you safer and healthier.

What is RSV?

RSV is a common respiratory virus that usually causes mild, cold-like symptoms. It spreads easily through droplets when an infected person coughs or sneezes, or by touching surfaces contaminated with the virus.

Key points:

  • RSV stands for respiratory syncytial virus.
  • It circulates seasonally, often peaking in fall and winter.
  • Reinfections can occur throughout life—even in adulthood.

Do adults get RSV?

Yes. While RSV is best known for causing severe infections in infants and young children, adults of all ages can contract it. In most healthy adults, RSV causes symptoms similar to a mild cold:

  • Runny or stuffy nose
  • Sore throat
  • Cough
  • Mild headache
  • Low-grade fever
  • Fatigue

Symptoms usually appear 4–6 days after exposure and resolve within one to two weeks.

Why isn’t RSV just a “child’s illness”?

  • Reinfection is common. Immunity after an RSV infection wanes quickly.
  • Virus variability. Multiple strains circulate each season, allowing reinfection.
  • Similar symptoms. In adults, mild cases may be mistaken for the common cold or flu.

Who is at highest risk for severe RSV?

Although most healthy adults experience only mild illness, certain groups face higher risks of complications—including pneumonia and bronchitis—that may require hospitalization.

High-risk groups include:

  • Older adults (65 years and older).
    • Age-related changes in immune response
    • Presence of chronic health conditions
  • People with chronic heart or lung disease.
    • Congestive heart failure
    • Chronic obstructive pulmonary disease (COPD)
    • Asthma
  • Individuals with weakened immune systems.
    • Cancer treatment, organ transplant recipients
    • HIV/AIDS, immunosuppressive medications
  • Adults with serious neurological or neuromuscular conditions.
    • Impaired ability to clear secretions
  • Pregnant women.
    • Though risk of severe RSV is lower than for flu, caution is advised

Signs of severe illness

Seek medical attention if you experience:

  • High fever (over 102°F or 38.9°C)
  • Rapid or difficult breathing
  • Wheezing
  • Chest pain
  • Dehydration (dry mouth, little or no urine)
  • Confusion or severe lethargy

For non-urgent concerns, you might start with a free, online symptom check, using the doctor approved Ubie Symptom Checker.

How is RSV diagnosed in adults?

Diagnosis often relies on clinical evaluation. In mild cases, testing may not be necessary. However, if your symptoms are severe or you belong to a high-risk group, your healthcare provider may order:

  • Nasal or throat swab for RSV antigen or PCR testing
  • Chest X-ray (if pneumonia is suspected)
  • Blood tests (to check white blood cell counts, oxygen levels)

Treatment and management

There’s no specific antiviral treatment approved for RSV in most healthy adults. Management focuses on relieving symptoms and preventing complications.

Self-care measures:

  • Rest and limit physical activity.
  • Stay hydrated: water, broth, electrolyte solutions.
  • Use saline nasal sprays or rinses for congestion.
  • Take over-the-counter pain relievers (acetaminophen or ibuprofen) for fever and aches.
  • Use a humidifier to moisten air and ease breathing.

For high-risk adults or severe cases:

  • Supplemental oxygen in hospital settings.
  • Intravenous fluids if dehydration occurs.
  • Mechanical ventilation or noninvasive ventilation (in critical cases).
  • Ribavirin (a specific antiviral) may be used rarely in immunocompromised patients.

Preventing RSV in adults

Although you can’t eliminate risk entirely, these steps help reduce your chances of getting RSV or passing it on:

  1. Practice good hand hygiene

    • Wash hands with soap and water for ≥20 seconds.
    • Use alcohol-based hand sanitizers when washing isn’t possible.
  2. Avoid close contact with sick individuals

    • Keep distance if someone is coughing or sneezing.
    • Don’t share utensils, cups, or towels.
  3. Clean and disinfect surfaces

    • Focus on doorknobs, light switches, phones, and countertops.
  4. Cover coughs and sneezes

    • Use a tissue or your elbow, not your hands.
  5. Stay home when ill

    • Prevent spreading the virus to coworkers, family, and high-risk individuals.
  6. Consider vaccination (where available)

    • New RSV vaccines for older adults are becoming available.
    • Speak with your doctor about whether RSV vaccination is right for you.

RSV vs. flu vs. COVID-19

RSV, influenza, and COVID-19 can all cause respiratory symptoms. Here’s a quick comparison:

Feature RSV Flu COVID-19
Onset Gradual (4–6 days) Sudden (1–4 days) Gradual to sudden (2–14 days)
Fever Low or none Common, often high Common, variable
Aches & chills Mild Prominent Prominent
Cough Common Common Common
Severe complications Mostly in high-risk High in high-risk High in high-risk

Accurate diagnosis may require testing since symptoms overlap. If you’re unsure which illness you have, try a free, online symptom check, using the doctor approved Ubie Symptom Checker.

When to see a doctor

Contact your healthcare provider if you:

  • Belong to a high-risk group and develop RSV symptoms.
  • Have trouble breathing, chest pain, or rapid heart rate.
  • Experience persistent high fever or confusion.
  • Can’t keep fluids down, leading to dehydration.

Never ignore symptoms that feel serious or life threatening. If you’re in crisis (severe breathing difficulty, chest pain, sudden confusion), call emergency services immediately.

Key takeaways

  • Adults of all ages can get RSV; most cases are mild.
  • Severe illness is more likely in older adults, those with chronic conditions, and immunocompromised individuals.
  • No specific treatment exists for most adults—care is supportive.
  • Prevent COVID-19 and flu-like viruses with good hygiene, distancing, and vaccination where appropriate.
  • Use the Ubie Symptom Checker for a free, online symptom check, using the doctor approved Ubie Symptom Checker.
  • Speak to a doctor about anything that could be life threatening or serious.

Staying informed and taking simple precautions goes a long way in protecting yourself and your community from RSV and other respiratory viruses. If you’re ever in doubt about your symptoms, always reach out to a healthcare professional.

(References)

  • * Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009 Feb 5;360(6):588-98. doi: 10.1056/NEJMoa0804877. PMID: 19196675; PMCID: PMC4829966.

  • * Buchwald AG, Tamboura B, Tennant SM, Haidara FC, Coulibaly F, Doumbia M, Diallo F, Keita AM, Sow SO, Kotloff KL, Levine MM, Tapia MD. Epidemiology, Risk Factors, and Outcomes of Respiratory Syncytial Virus Infections in Newborns in Bamako, Mali. Clin Infect Dis. 2020 Jan 1;70(1):59-66. doi: 10.1093/cid/ciz157. PMID: 30810160; PMCID: PMC6912158.

  • * Khan L. Respiratory Syncytial Virus. Pediatr Ann. 2022 Oct;51(10):e376-e378. doi: 10.3928/19382359-20220807-01. Epub 2022 Oct 1. PMID: 36215084.

  • * Wang X, Li Y, Shi T, Bont LJ, Chu HY, Zar HJ, Wahi-Singh B, Ma Y, Cong B, Sharland E, Riley RD, Deng J, Figueras-Aloy J, Heikkinen T, Jones MH, Liese JG, Markić J, Mejias A, Nunes MC, Resch B, Satav A, Yeo KT, Simões EAF, Nair H, Respiratory Virus Global Epidemiology Network, RESCEU investigators. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data. Lancet. 2024 Mar 30;403(10433):1241-1253. doi: 10.1016/S0140-6736(24)00138-7. Epub 2024 Feb 14. PMID: 38367641.

  • * Deng S, Cong B, Edgoose M, De Wit F, Nair H, Li Y. Risk factors for respiratory syncytial virus-associated acute lower respiratory infection in children under 5 years: An updated systematic review and meta-analysis. Int J Infect Dis. 2024 Sep;146:107125. doi: 10.1016/j.ijid.2024.107125. Epub 2024 Jun 28. PMID: 38945430.

  • * Kirolos N, Mtaweh H, Datta RR, Farrar DS, Seaton C, Bone JN, Muttalib F, Kaziev CL, Fortini J, Mahant S, Campigotto A, Freire G, Yeung RSM, Rayment JH, Yang C, Srigley JA, Sadarangani M, Buchanan F, Morris SK, Gill PJ, READAPT-Kids Study Group Members. Risk Factors for Severe Disease Among Children Hospitalized With Respiratory Syncytial Virus. JAMA Netw Open. 2025 Apr 1;8(4):e254666. doi: 10.1001/jamanetworkopen.2025.4666. Epub 2025 Apr 1. PMID: 40214990; PMCID: PMC11992603.

  • * Ma R, Zhang C, Zhang Y, Tan H, Zhang Y, Li Q, Bai Y, Sun X. The impact of respiratory syncytial virus on asthma development and exacerbation. Ann Allergy Asthma Immunol. 2025 Sep;135(3):268-275. doi: 10.1016/j.anai.2025.05.011. Epub 2025 May 17. PMID: 40389152.

  • * Goldstein LA, Michaels MG, Salthouse A, Toepfer AP, Musa S, Hickey RW, Johnson M, Wang-Erickson AF, Weinberg GA, Szilagyi PG, Schlaudecker EP, Staat MA, Sahni LC, Boom JA, Klein EJ, Englund JA, Schuster JE, Selvarangan R, Harrison CJ, Halasa NB, Stewart LS, Dawood FS, Moline HL, Williams JV. Human Metapneumovirus and Respiratory Syncytial Virus in Children: A Comparative Analysis. Pediatrics. 2025 Sep 1;156(3). doi: 10.1542/peds.2024-070218. PMID: 40763933; PMCID: PMC12824835.

  • * Buttarelli L, Caselli E, Gerevini S, Leuratti P, Gambadauro A, Manti S, Esposito S. Predictive Factors and Clinical Markers of Recurrent Wheezing and Asthma After RSV Infection. Viruses. 2025 Jul 31;17(8). doi: 10.3390/v17081073. Epub 2025 Jul 31. PMID: 40872787; PMCID: PMC12390669.

  • * Frivold C, Cox SN, Starita L, Babu TM, Hoffman KL, Carone M, Lockwood CM, Kuntz JL, Mularski RA, Varga A, Han PD, Reed J, Piliper EA, Mohamed Bakhash SAK, Greninger AL, Clark E, Stone J, Grindstaff S, Boisvert CL, Yetz N, Lo NK, Hatchie TL, Marshall G, Wolock CJ, Feldstein LR, Weil AA, Englund JA, Naleway AL, Chu HY. Correlates of risk of respiratory syncytial virus disease: a prospective cohort study. Nat Commun. 2025 Sep 26;16(1):8490. doi: 10.1038/s41467-025-63434-x. Epub 2025 Sep 26. PMID: 41006233; PMCID: PMC12475016.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.